Optimal doses for combination treatment with NU7026 and IR were studied in the neuroblastoma cell line NGP because of the high PRKDC mRNA expression in this cell line, as determined by Affymetrix microarray analysis (S1 Fig). Here, PRKDC is linked to neuroblastoma.